Skip to main content
. 2022 Jun 10;14(6):1228. doi: 10.3390/pharmaceutics14061228

Figure 3.

Figure 3

(A) General strategy for the conjugation of the antigen (OVA) to mIONPsp. (B) Schematic of the self-assembly process for the synthesis of the water-soluble and pathogen-mimicking nanoparticles (NP micelles (mNP) incorporating Xcc or E. coli LOS molecules). (C) The function of pathogen-mimicking magnetite nanoparticles via the TLR4 pathway.Reprinted with permission from Ref. [84]. Copyright 2018, copyright Wiley-VCH. (D) Schematic representation of the fabrication of IMDQnano. Reprinted with permission from Ref. [76]. Copyright 2018, copyright Wiley-VCH.